RNA, Technology and IP Attorneys

Ranjan Narula and Shipra Alisha Philip of RNA, Technology and IP Attorneys explore the factors driving rapid growth in India's medical tourism industry as fraudulent healthcare providers attempt to cash in

Ranjan Narula and Shipra Alisha Philip of RNA, Technology and IP Attorneys analyse how a US ruling could affect digital libraries, e-book licensing, and public access to knowledge in India

Ranjan Narula, Abhishek Nangia, and Shakti Priyan Nair of RNA, Technology and IP Attorneys outline various progressive and business-friendly changes under the Jan Vishwas (Amendment of Provisions) Act, 2023, but identify several potential issues

Ranjan Narula and Suvarna Pandey of RNA, Technology and IP Attorneys consider the implications of a High Court of Delhi ruling concerning a patented compound used to treat non-small cell lung cancer

A decision by the High Court of Delhi has confirmed that the denigration of another brand in comparative advertising crosses the line, say Ranjan Narula and Daleep Kumar of RNA, Technology and IP Attorneys

Ranjan Narula and Suvarna Pandey of RNA Technology and IP Attorneys welcome the introduction of India’s new patent rules and highlight the key changes